Source: International Congress 2018 – General thoracic surgery
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
S. Elia (Rome, Italy), G. D'Angelo (Benevento, Italy), A. De Stefano (Rome, Italy), R. Massoud (Rome, Italy), R. Sorge (Rome, Italy), C. Cortese (Rome, Italy). Tumor marker assessment in cytologically negative pleural effusions from lung cancer by Machine Learning-based approach. 3842

Member's Comments

No comment yet.

Related content which might interest you: Diagnostic utility of cell block method combined with conventional smear cytology in the diagnosis of exudative pleural effusions accompanying lung cancer Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases Year: 2013 Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management Year: 2015 The utility of survivin mRNA as a diagnostic biomarker in lung cancer with malignant pleural effusion Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions Year: 2013 Predictive parameters of survival in malignant pleural effusion Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015 Diagnostic value of pleural fluid angiopoietin-2 (Ang-2) levels, to differentiate malignant pleural effusions from benign pleural effusions Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016 Thoracoscopy in malignant pleural effusions secondary to breast cancer Source: Eur Respir J 2006; 28: Suppl. 50, 611s Year: 2006 Lent score validation on patients with malignant pleural effusion Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016 Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer with malignant pleural effusions Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology Year: 2012 Biochemical and cytological features of metastatic pleural effusions in breast cancer Source: Eur Respir J 2007; 30: Suppl. 51, 671s Year: 2007 Clinical and biological prognostic factors in malignant pleural effusion (MPE) secondary to breast cancer Source: Annual Congress 2005 - What's new in the pleura Year: 2005 Prognostic value of metabolic imaging in non small cell lung cancers with neoplasic pleural effusion Source: Eur Respir J 2007; 30: Suppl. 51, 206s Year: 2007 Detection of mesothelin in the pleural effusion has a higher diagnostic utility than in serum for diagnostic of malignant mesothelioma Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013 Comparison between mesothelin and fibulin-3 detection in pleural malignant mesothelioma (MPM) patients Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016 The role of surgery in cytologically positive pleural effusion in NSCLC Source: Annual Congress 2003 - Lung cancer surgery: prognostic factors Year: 2003 CT scanner for the pleural staging of pleural cancer: How accurate is this? Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Utility of pleural fluid for predictive marker testing in malignant pleural effusion Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications Year: 2020 EBUS-TBNA, EUS-FNA or EUS-B-FNA for mediastinal staging of lung cancer: A purpose of diagnostic algorithm Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Diagnostic value of pleural effusion for the detection of EGFR in NSCLC: a meta-analysis Source: International Congress 2019 – Diagnosis of lung cancer Year: 2019 Pleural effusions in lung cancer Source: Annual Congress 2012 - Clinical issues in malignant pleural effusions Year: 2012 An update on treatment of malignant pleural effusion with or without known primary bronchial adenocarcinoma Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis Year: 2006